Stay updated on Alternative Schedule Study for VLA15 Clinical Trial
Sign up to get notified when there's something new on the Alternative Schedule Study for VLA15 Clinical Trial page.

Latest updates to the Alternative Schedule Study for VLA15 Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPublications section updated with two 2024 Lancet Infectious Diseases papers on VLA15 booster immunisation and dose optimization.SummaryDifference0.4%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedMajor change: updated operating status notice and new version v3.2.0; removed previous version v3.1.0.SummaryDifference1%

- Check49 days agoChange DetectedUpdate to version v3.1.0 with removal of several drug-safety topics; indicates content reorganization/revision rather than new substantive information in the deleted areas.SummaryDifference0.1%

- Check63 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. No substantive changes to core content, pricing, or time-sensitive information are evident.SummaryDifference0.1%

- Check70 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%

- Check78 days agoChange DetectedThe web page has been updated to include new facility names, locations, and publications related to the VLA15 Lyme borreliosis vaccine candidate, while removing specific geographic details and previous vaccine references.SummaryDifference4%

Stay in the know with updates to Alternative Schedule Study for VLA15 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alternative Schedule Study for VLA15 Clinical Trial page.